Potassium Iodide: 7 Key Indications, Dosage & Safety Profile
Comprehensive guide to potassium iodide uses, mechanisms, dermatological applications, dosing, and safety in medicine.
Author: Expert Dermatologist (synthesized from peer-reviewed sources)
Potassium iodide (KI) is a versatile medication with applications spanning dermatology, radiology, endocrinology, and pulmonology. Historically used since the 19th century, it modulates immune responses, acts as an antifungal agent, serves as an expectorant, and protects the thyroid during radiation emergencies. This article details its pharmacology, clinical uses, dosing, and safety profile.
What is potassium iodide?
Potassium iodide is an inorganic salt composed of potassium and iodide ions, available as oral solutions, saturated solution (SSKI), tablets, or topical preparations. It provides bioavailable iodine essential for thyroid hormone synthesis but exerts diverse effects at therapeutic doses, including neutrophil inhibition and antimicrobial action.
In dermatology, KI’s resurgence stems from its efficacy in neutrophilic and granulomatous conditions unresponsive to conventional therapies. Mechanisms include suppression of neutrophil chemotaxis and toxic oxygen radical production, akin to dapsone.
History
Introduced in 1811, KI was initially employed for syphilis, asthma, and tuberculosis. By the mid-20th century, it treated fungal infections like sporotrichosis. Modern use expanded to inflammatory dermatoses following reports of rapid resolution in Sweet syndrome and erythema nodosum.
Its role in nuclear incidents, such as Chernobyl, solidified KI as a radioprotectant, blocking radioactive iodine-131 uptake by saturating thyroid receptors.
Pharmacology and mechanism of action
KI’s pleiotropic effects arise from multiple pathways:
- Anti-inflammatory: Inhibits neutrophil chemotaxis and superoxide production at doses of 15 mg/kg/day orally, observed in vivo within three days.
- Antimicrobial: Topical KI disinfects via iodination of microbial proteins; oral KI lyses Sporothrix schenckii yeast through lysosomal enzyme release, despite lacking in vitro antifungal activity.
- Expectorant: At 2% concentration (20 mg/mL), irritates respiratory mucosa to enhance mucus clearance in emphysema or cystic fibrosis.
- Thyroid protection: Saturates thyroid iodine receptors, preventing radioiodine absorption; non-radioactive iodine is preferentially taken up, with excess excreted renally.
KI acts as a thyroid blocker in hyperthyroidism, temporarily halting hormone release, useful pre-thyroidectomy.
DermNet Topic Pages related to infections
Indications in dermatology
Infectious dermatoses
KI excels in deep fungal infections. For sporotrichosis, oral KI (2.5–7.5 g/day SSKI in adults) induces lesion resolution in 4–6 weeks, superior to itraconazole in some cases.
Zygomycosis and other mycoses respond similarly. Topically, KI treats impetigo and omphalitis as an antiseptic.
Neutrophilic dermatoses
Sweet syndrome (acute febrile neutrophilic dermatosis) shows dramatic improvement within days at 900 mg/day (30–40 drops SSKI thrice daily), with fever and plaques resolving rapidly.
Pyoderma gangrenosum heals with 3–6 g/day, often combined with corticosteroids. Behçet’s syndrome benefits from neutrophil modulation, alleviating oral ulcers and skin lesions.
Panniculitides
Erythema nodosum responds in 70–90% of cases within two weeks at 0.9–1.3 g/day, especially with systemic symptoms and elevated CRP. Nodular vasculitis and subacute migratory panniculitis follow suit.
Miscellaneous dermatoses
Granuloma annulare (including generalized forms), erythema multiforme (HSV-associated), erythema annulare centrifugum, and granulomatosis with polyangiitis (Wegener) improve with KI.
Other indications
Radiation emergencies
KI is FDA-approved for thyroid blocking in nuclear accidents. Administered promptly post-exposure, it reduces thyroid cancer risk, particularly in children <18 years, pregnant women, and adults <40.
Dosage: Adults 130 mg single dose; children 16–65 mg based on age/weight; neonates/infants lower. Repeat only if exposure persists. Over-40s avoid unless massive exposure due to low thyroid cancer risk.
Limitations: Protects only thyroid from I-131, not other radionuclides or body parts.
Respiratory conditions
As a mucolytic expectorant for chronic bronchitis, emphysema, or cystic fibrosis.
Hyperthyroidism
Dose and administration
| Indication | Adult Dose | Pediatric Dose | Duration |
|---|---|---|---|
| Sporotrichosis | 2.5–5 g/day SSKI (40–75 drops TID) | 0.1 g/kg/day | 4–6 weeks |
| Sweet syndrome/PG | 0.9–6 g/day | 30–50 mg/kg/day | Until resolution |
| Radiation emergency | 130 mg single dose | 16–65 mg (age-based) | 1 dose; repeat if needed |
| Expectorant | 300–600 mg TID | Weight-based | Symptomatic |
SSKI: 1 drop = 0.05 mL = 25–50 mg iodide. Start low, titrate. Oral solution preferred for palatability.
Adverse effects
Common: GI upset, sialadenitis, metallic taste, acneiform eruptions, rhinorrhea (iodism).
Serious: Hypersensitivity (rash, angioedema, anaphylaxis), thyroid dysfunction (hypo/hyperthyroidism, goiter), arrhythmias, iododerma (vegetating plaques).
- Allergic reactions: Rash, hives, swelling, dyspnea—seek immediate care.
- Thyroid: Monitor in preexisting disease (Graves, Hashimoto).
Monitoring
- Baseline thyroid function (TSH, FT4).
- Weekly during prolonged therapy >2 weeks.
- Renal function, electrolytes.
- Symptom resolution, lesion photography.
Drug interactions and contraindications
Contraindications: Hypersensitivity, active thyroid disease (unless monitored), pregnancy (beyond single radiation dose), neonates with hyperthyroidism risk.
Interactions: Lithium, antithyroids potentiate hypothyroidism; ACE inhibitors increase hyperkalemia.
Precautions
Use cautiously in renal impairment, elderly, pregnancy (Category D chronic use). Single radiation dose safe in pregnancy.
id=’frequently-asked-questions’>Frequently asked questions
What is the main use of potassium iodide in dermatology?
Primarily for neutrophilic dermatoses like Sweet syndrome and sporotrichosis due to neutrophil inhibition and antifungal effects.
Is potassium iodide safe for radiation emergencies?
Yes, as a single dose per CDC guidelines; protects thyroid from I-131 but not other radiation. Prioritize children and pregnant women.
Can KI cause thyroid problems?
Yes, potential hypo/hyperthyroidism; monitor TSH in long-term use or preexisting thyroid disease.
How quickly does KI work for Sweet syndrome?
Fever and lesions improve within 1–2 days; full resolution in 1–2 weeks.
Is topical KI effective?
Yes, as antiseptic for wounds; oral for systemic mycoses.
References
- Use of potassium iodide in Dermatology: updates on an old drug — PMC/NIH. 2013-08-15. https://pmc.ncbi.nlm.nih.gov/articles/PMC3754371/
- Potassium Iodide — The Medical Group of New Jersey. 2023. https://sussexheart.com/health-library/healthwise?DOCHWID=a611043
- Potassium Iodide (KI) Types, Benefits & Side Effects — Cleveland Clinic. 2024-06-12. https://my.clevelandclinic.org/health/treatments/potassium-iodide-ki
- Potassium iodide is in the news. Here’s what it’s all about — UCHealth. 2024. https://www.uchealth.org/today/potassium-iodide-in-the-news-why/
- Potassium Iodide (KI) Fact Sheet — Orange County Health. 2023. https://www.ochealthinfo.com/sites/hca/files/import/data/files/13647.pdf
- How Potassium Iodide (KI) Works | Radiation Emergencies — CDC. 2024-01-10. https://www.cdc.gov/radiation-emergencies/infographic/potassium-iodide.html
- Potassium Iodide — Memorial Sloan Kettering Cancer Center. 2024. https://www.mskcc.org/cancer-care/patient-education/medications/adult/potassium-iodide
Similar Articles
Read full bio of medha deb
